Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microvision (MVIS) -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (4494)	3/24/2000 10:38:00 AM
From: kili	Read Replies (1) \| Respond to of 7720

Dear JDN, Can't quite see why this should affect MVIS. IMO, XYBR represents an obvious forerunner for an equally obvious use of VRD. R&D co.s need funding to get where they want to be. Some make it -some don't. New economy companies (I choose to put these advanced forerunners in that category) will raise needed funding as long as the investors believe they are on to something potent. MVIS seems to be doing very well in that respect, and they've managed to keep the market satisfied that funding is available for as long as it's needed before revenues start taking the lead. CREE - Gemfire - XYBR - Boeing - Nokia? - Intel? - Zeiss - and the rest of them: Some new, some old, some great, some small: Great innovations in good hands will succeed, and I'm sure MVIS has/is/will do just that. From sunny and springlike Bergen: Have an excellent weekend! Kim

To: JDN who wrote (4494)	3/24/2000 10:42:00 AM
From: Steve	Respond to of 7720

I very much doubt it. 1. XYBR is the real thing. They (imho) will be announcing something with IBM very soon. IBM's Annual Report is sprinkled with refs to wearables and Steve Mills just demo-ed one recently, on top of the ongoing ad campaign. 2. The shorts initial ammo was a well-timed and insubstantial news report from Bloomberg, and XYBR's historical financing "issues" - warrants, PPs. Sound familiar ? MVIS has done all of this in the past and now has moved beyond this phase, just as XYBR is about to. Anything under $20 is a real deal. 3. On XYBR SI this morning we have the shorts' "last resort" - digging up spurious "commercially-available" killer competitors (Carnegie Mellon University, Epson). Again, this tactic should sound familiar if you have been following the Uetani fiasco on the MVIS Yahoo board. MVIS will be very happy with this XYBR hookup. We will probably see better PR for MVIS from XYBR than from MVIS, unless MVIS is about to undergo a Damascene conversion and start telling us what the hell they're up to. For example, did you listen to the XYBR CEO's interview yesterday on radiowallstreet.com where he mentioned shipping MVIS/XYBR units into the medical arena in the next few months ?